202 related articles for article (PubMed ID: 24586389)
21. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
Amin R; Waters V
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD009249. PubMed ID: 27415821
[TBL] [Abstract][Full Text] [Related]
22. Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia.
Waters VJ; Gómez MI; Soong G; Amin S; Ernst RK; Prince A
Infect Immun; 2007 Apr; 75(4):1698-703. PubMed ID: 17220304
[TBL] [Abstract][Full Text] [Related]
23. Stenotrophomonas maltophilia strains replicate and persist in the murine lung, but to significantly different degrees.
Rouf R; Karaba SM; Dao J; Cianciotto NP
Microbiology (Reading); 2011 Jul; 157(Pt 7):2133-2142. PubMed ID: 21546584
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis.
Talmaciu I; Varlotta L; Mortensen J; Schidlow DV
Pediatr Pulmonol; 2000 Jul; 30(1):10-5. PubMed ID: 10862157
[TBL] [Abstract][Full Text] [Related]
25. Stenotrophomonas maltophilia Encodes a VirB/VirD4 Type IV Secretion System That Modulates Apoptosis in Human Cells and Promotes Competition against Heterologous Bacteria, Including Pseudomonas aeruginosa.
Nas MY; White RC; DuMont AL; Lopez AE; Cianciotto NP
Infect Immun; 2019 Sep; 87(9):. PubMed ID: 31235638
[No Abstract] [Full Text] [Related]
26. Cooperativity between Stenotrophomonas maltophilia and Pseudomonas aeruginosa during Polymicrobial Airway Infections.
McDaniel MS; Schoeb T; Swords WE
Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31932329
[No Abstract] [Full Text] [Related]
27. Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia.
Lehoux Dubois C; Boudreau V; Tremblay F; Lavoie A; Berthiaume Y; Rabasa-Lhoret R; Coriati A
J Cyst Fibros; 2017 May; 16(3):418-424. PubMed ID: 28284526
[TBL] [Abstract][Full Text] [Related]
28. Stenotrophomonas maltophilia interaction with human epithelial respiratory cells in vitro.
De Vidipó LA; De Marques EA; Puchelle E; Plotkowski MC
Microbiol Immunol; 2001; 45(8):563-9. PubMed ID: 11592630
[TBL] [Abstract][Full Text] [Related]
29. Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients.
Pompilio A; Crocetta V; Confalone P; Nicoletti M; Petrucca A; Guarnieri S; Fiscarelli E; Savini V; Piccolomini R; Di Bonaventura G
BMC Microbiol; 2010 Apr; 10():102. PubMed ID: 20374629
[TBL] [Abstract][Full Text] [Related]
30. Proteomic analysis of outer membrane proteins and vesicles of a clinical isolate and a collection strain of Stenotrophomonas maltophilia.
Ferrer-Navarro M; Torrent G; Mongiardini E; Conchillo-Solé O; Gibert I; Daura X
J Proteomics; 2016 Jun; 142():122-9. PubMed ID: 27185551
[TBL] [Abstract][Full Text] [Related]
31. Molecular Characterization of Stenotrophomonas maltophilia isolates from cystic fibrosis patients and the hospital environment.
Marzuillo C; De Giusti M; Tufi D; Giordano A; Del Cimmuto A; Quattrucci S; Mancini C; Villari P
Infect Control Hosp Epidemiol; 2009 Aug; 30(8):753-8. PubMed ID: 19583515
[TBL] [Abstract][Full Text] [Related]
32. Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis.
Dalbøge CS; Hansen CR; Pressler T; Høiby N; Johansen HK
J Cyst Fibros; 2011 Sep; 10(5):318-25. PubMed ID: 21463972
[TBL] [Abstract][Full Text] [Related]
33. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis.
Waters V; Atenafu EG; Salazar JG; Lu A; Yau Y; Matukas L; Tullis E; Ratjen F
J Cyst Fibros; 2012 Jan; 11(1):8-13. PubMed ID: 21849265
[TBL] [Abstract][Full Text] [Related]
34. Elevated metal concentrations in the CF airway correlate with cellular injury and disease severity.
Smith DJ; Anderson GJ; Bell SC; Reid DW
J Cyst Fibros; 2014 May; 13(3):289-95. PubMed ID: 24369896
[TBL] [Abstract][Full Text] [Related]
35. Stenotrophomonas maltophilia strains from cystic fibrosis patients: genomic variability and molecular characterization of some virulence determinants.
Nicoletti M; Iacobino A; Prosseda G; Fiscarelli E; Zarrilli R; De Carolis E; Petrucca A; Nencioni L; Colonna B; Casalino M
Int J Med Microbiol; 2011 Jan; 301(1):34-43. PubMed ID: 20952251
[TBL] [Abstract][Full Text] [Related]
36. Delineation of Stenotrophomonas maltophilia isolates from cystic fibrosis patients by fatty acid methyl ester profiles and matrix-assisted laser desorption/ionization time-of-flight mass spectra using hierarchical cluster analysis and principal component analysis.
Vidigal PG; Mosel F; Koehling HL; Mueller KD; Buer J; Rath PM; Steinmann J
J Med Microbiol; 2014 Dec; 63(Pt 12):1615-1620. PubMed ID: 25266870
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
[TBL] [Abstract][Full Text] [Related]
38. Adaptation of Stenotrophomonas maltophilia in cystic fibrosis: molecular diversity, mutation frequency and antibiotic resistance.
Vidigal PG; Dittmer S; Steinmann E; Buer J; Rath PM; Steinmann J
Int J Med Microbiol; 2014 Jul; 304(5-6):613-9. PubMed ID: 24836944
[TBL] [Abstract][Full Text] [Related]
39. Investigation of Stenotrophomonas maltophilia epidemiology in a French cystic fibrosis center.
Capaldo C; Beauruelle C; Saliou P; Rault G; Ramel S; Héry-Arnaud G
Respir Med Res; 2020 Nov; 78():100757. PubMed ID: 32759054
[TBL] [Abstract][Full Text] [Related]
40. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
Lobo LJ; Tulu Z; Aris RM; Noone PG
Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
